These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18021336)

  • 21. Evaluation of Cytochrome P450 (CYP) 3A4-Based Interactions of Levomilnacipran with Ketoconazole, Carbamazepine or Alprazolam in Healthy Subjects.
    Chen L; Boinpally R; Gad N; Greenberg WM; Wangsa J; Periclou A; Ghahramani P
    Clin Drug Investig; 2015 Oct; 35(10):601-12. PubMed ID: 26315684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of CYP3A inhibition on the metabolism of cilostazol.
    Suri A; Forbes WP; Bramer SL
    Clin Pharmacokinet; 1999; 37 Suppl 2():61-8. PubMed ID: 10702888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Ketoconazole and Rifampicin on the Pharmacokinetics of Nintedanib in Healthy Subjects.
    Luedtke D; Marzin K; Jungnik A; von Wangenheim U; Dallinger C
    Eur J Drug Metab Pharmacokinet; 2018 Oct; 43(5):533-541. PubMed ID: 29500603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of ketoconazole and rifampin on the single-dose pharmacokinetics of crizotinib in healthy subjects.
    Xu H; O'Gorman M; Tan W; Brega N; Bello A
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1441-9. PubMed ID: 26381275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ketoconazole on the pharmacokinetic properties of CG100649, a novel NSAID: a randomized, open-label crossover study in healthy Korean male volunteers.
    Youn Choi H; Jin SJ; Jung JA; Kim UJ; Ko YJ; Noh YH; Bae KS; Lim HS
    Clin Ther; 2014 Jan; 36(1):115-25. PubMed ID: 24417786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors.
    Arlander E; Ekström G; Alm C; Carrillo JA; Bielenstein M; Böttiger Y; Bertilsson L; Gustafsson LL
    Clin Pharmacol Ther; 1998 Nov; 64(5):484-91. PubMed ID: 9834040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide.
    Niemi M; Tornio A; Pasanen MK; Fredrikson H; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2006 Jun; 62(6):463-72. PubMed ID: 16758263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ascending single-dose study of the safety profile, tolerability, and pharmacokinetics of bosutinib coadministered with ketoconazole to healthy adult subjects.
    Abbas R; Leister C; El Gaaloul M; Chalon S; Sonnichsen D
    Clin Ther; 2012 Sep; 34(9):2011-9.e1. PubMed ID: 22884766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin.
    Ling SY; Huizinga RB; Mayo PR; Larouche R; Freitag DG; Aspeslet LJ; Foster RT
    Br J Clin Pharmacol; 2014 Jun; 77(6):1039-50. PubMed ID: 24330024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide.
    Hatorp V; Hansen KT; Thomsen MS
    J Clin Pharmacol; 2003 Jun; 43(6):649-60. PubMed ID: 12817528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers.
    Pithavala YK; Tong W; Mount J; Rahavendran SV; Garrett M; Hee B; Selaru P; Sarapa N; Klamerus KJ
    Invest New Drugs; 2012 Feb; 30(1):273-81. PubMed ID: 20740300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor.
    Frost CE; Byon W; Song Y; Wang J; Schuster AE; Boyd RA; Zhang D; Yu Z; Dias C; Shenker A; LaCreta F
    Br J Clin Pharmacol; 2015 May; 79(5):838-46. PubMed ID: 25377242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-way interaction study between ritonavir boosted danoprevir, a potent HCV protease inhibitor, and ketoconazole in healthy subjects.
    Morcos PN; Chang L; Navarro M; Chung D; Smith PF; Brennan BJ; Tran JQ
    Int J Clin Pharmacol Ther; 2014 Feb; 52(2):103-11. PubMed ID: 24290411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting drug candidate victims of drug-drug interactions, using microdosing.
    Croft M; Keely B; Morris I; Tann L; Lappin G
    Clin Pharmacokinet; 2012 Apr; 51(4):237-46. PubMed ID: 22335429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole.
    Floren LC; Bekersky I; Benet LZ; Mekki Q; Dressler D; Lee JW; Roberts JP; Hebert MF
    Clin Pharmacol Ther; 1997 Jul; 62(1):41-9. PubMed ID: 9246018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers.
    Liu Y; Zhou S; Wan Y; Wu A; Palmisano M
    Br J Clin Pharmacol; 2014 Nov; 78(5):1050-7. PubMed ID: 24962564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole.
    Robert M; Salvà M; Segarra R; Pavesi M; Esbri R; Roberts D; Golor G
    Drug Metab Dispos; 2007 Jul; 35(7):1149-56. PubMed ID: 17437965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ketoconazole on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor teneligliptin: an open-label study in healthy white subjects in Germany.
    Nakamaru Y; Hayashi Y; Sekine M; Kinoshita S; Thompson J; Kawaguchi A; Davies M; Jürgen Heuer H; Yamazaki H; Akimoto K
    Clin Ther; 2014 May; 36(5):760-9. PubMed ID: 24726088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.